2015 annual financial data

Alnylam Pharmaceuticals 2015 Net margin

Direct answer

Net margin was -705.83%.

Operating income was -296.01M USD and net income was -290.07M USD.
Operating cash flow was -189.14M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
41.1M USD
Operating income
-296.01M USD
Net income
-290.07M USD
Operating cash flow
-189.14M USD